NCT01535599View on ClinicalTrials.gov

Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa

PHASE3CompletedINTERVENTIONAL
Enrollment

768

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Acute Otitis Externa
Interventions
DRUG

AL-60371, 0.3% Otic Suspension

OTHER

AL-60371 Vehicle

Inactive ingredients used as a placebo comparator

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY